Put Options

32 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $5.75 Million - $7.83 Million
450,000 Added 450000.0%
450,100 $7.31 Million
Q1 2024

May 15, 2024

SELL
$10.67 - $14.43 $15 Million - $20.3 Million
-1,405,100 Reduced 99.99%
100 $1,000
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $1.67 Million - $2.18 Million
205,300 Added 17.11%
1,405,200 $14.7 Million
Q3 2023

Nov 14, 2023

SELL
$7.48 - $10.7 $137,632 - $196,880
-18,400 Reduced 1.51%
1,199,900 $12.2 Million
Q2 2023

Aug 14, 2023

SELL
$7.2 - $9.47 $687,600 - $904,385
-95,500 Reduced 7.27%
1,218,300 $9.17 Million
Q1 2023

May 15, 2023

SELL
$8.36 - $11.37 $6.99 Million - $9.51 Million
-836,200 Reduced 38.89%
1,313,800 $11.6 Million
Q4 2022

Feb 14, 2023

BUY
$7.95 - $9.48 $2.47 Million - $2.94 Million
310,200 Added 16.86%
2,150,000 $19.6 Million
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $8.16 Million - $14.2 Million
1,190,100 Added 183.18%
1,839,800 $14.8 Million
Q2 2022

Aug 15, 2022

SELL
$7.38 - $10.4 $515,862 - $726,960
-69,900 Reduced 9.71%
649,700 $4.89 Million
Q1 2022

May 16, 2022

BUY
$7.33 - $9.39 $5.27 Million - $6.76 Million
719,600 New
719,600 $6.76 Million
Q4 2021

Feb 14, 2022

SELL
$7.9 - $10.19 $8.86 Million - $11.4 Million
-1,121,900 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$7.9 - $10.19 $1.1 Million - $1.42 Million
139,000 Added 14.14%
1,121,900 $8.99 Million
Q3 2021

Nov 15, 2021

BUY
$8.38 - $10.18 $8.24 Million - $10 Million
982,900 New
982,900 $9.57 Million
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $5.48 Million - $6.66 Million
-654,400 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$9.9 - $11.56 $6.48 Million - $7.56 Million
654,400 New
654,400 $6.48 Million
Q1 2021

May 14, 2021

SELL
$10.34 - $12.81 $9.32 Million - $11.6 Million
-901,800 Reduced 79.68%
230,000 $2.65 Million
Q1 2021

May 14, 2021

SELL
$10.34 - $12.81 $2.38 Million - $2.95 Million
-230,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$8.61 - $11.04 $9.74 Million - $12.5 Million
1,131,800 New
1,131,800 $10.9 Million
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $7.37 Million - $9.45 Million
-855,800 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$8.57 - $12.69 $4.28 Million - $6.33 Million
-499,100 Reduced 36.84%
855,800 $7.71 Million
Q2 2020

Aug 14, 2020

SELL
$8.12 - $13.12 $449,847 - $726,848
-55,400 Reduced 3.93%
1,354,900 $16.7 Million
Q1 2020

May 15, 2020

BUY
$6.69 - $13.45 $4.8 Million - $9.65 Million
717,300 Added 103.51%
1,410,300 $12.7 Million
Q4 2019

Feb 14, 2020

SELL
$6.53 - $10.72 $1.28 Million - $2.11 Million
-196,500 Reduced 22.09%
693,000 $6.79 Million
Q3 2019

Nov 14, 2019

BUY
$6.16 - $9.6 $1.76 Million - $2.74 Million
285,300 Added 47.22%
889,500 $6.12 Million
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $1.8 Million - $3.48 Million
221,200 Added 57.75%
604,200 $5.58 Million
Q1 2019

May 15, 2019

BUY
$15.58 - $20.01 $4.25 Million - $5.45 Million
272,600 Added 246.92%
383,000 $6.01 Million
Q4 2018

Feb 14, 2019

SELL
$14.59 - $23.84 $2.71 Million - $4.43 Million
-186,000 Reduced 62.75%
110,400 $1.7 Million
Q3 2018

Nov 14, 2018

BUY
$21.06 - $25.65 $3.61 Million - $4.4 Million
171,400 Added 137.12%
296,400 $6.39 Million
Q2 2018

Aug 14, 2018

SELL
$16.77 - $24.71 $47.2 Million - $69.6 Million
-2,817,200 Reduced 95.75%
125,000 $3.04 Million
Q1 2018

May 15, 2018

BUY
$16.68 - $22.07 $30.8 Million - $40.8 Million
1,847,200 Added 168.69%
2,942,200 $50.3 Million
Q4 2017

Feb 14, 2018

BUY
$11.23 - $19.1 $9.49 Million - $16.1 Million
845,000 Added 338.0%
1,095,000 $20.8 Million
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $3.85 Million - $8.04 Million
250,000
250,000 $4.4 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.